This Sources Sought opportunity from Department Of Defense was posted on May 11, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Compound Mixtures

Closed

HT0014Federal

Submission Closed05/11/2021, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Health Agency (DHA) Contracting Office for the National Capital Region plans to award multiple Blanket Purchase Agreements (BPAs) for commercial medical implants, components, instruments, and related items. These supplies will be sourced from vendors' commercial catalogs and price lists, covering various Federal Supply Classes associated with medical and hospital needs, such as 6505, 6506, 6515, 6520, J065, and J070. The intended duration for these agreements is up to five years, and they are designed to support facilities including Fort Belvoir Community Hospital, Walter Reed National Medical Center, and other Military Treatment Facilities. This notice is a special notice intended solely to gather information and identify interested and capable vendors by August 16, 2017, rather than a solicitation for competitive proposals. The information received will be used to determine potential BPA awards for future requirements. The BPA awards aim to provide needed medical items efficiently for DHA's medical facilities. It is important to note that this notice does not legally bind the government or commit to any purchases, and interested vendors assume all costs related to their response. The contracting office can be contacted through the provided point of contact in Falls Church, VA.

General Info

DHA plans multiple five-year BPAs for commercial medical implants, supporting military medical facilities.

Agency

Department Of Defense → Defense Health Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Bethesda, MD, 20889, USA

Set-Aside

SBA

Documents

RFQ - Forklift (Combi-Lift WR-3200)

rfq

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

4 updates

PhaseClosed

PostedJul 27

special-notice

Notice updatedDec 16

Notice type changed from Special Notice to Solicitation. Response deadline added: Dec 22, 2020. The notice title changed. NAICS code changed from 339112 to 333924. Set-aside added: Total Small Business Set-Aside (FAR 19.5). The notice description changed. The point of contact changed.

Notice updatedDec 16

The notice title changed. The point of contact changed.

Notice updatedDec 16

Notice details unchanged. Attachments may have changed.

Notice updatedDec 18

The notice description changed.

Response DeadlineMay 11

Deadline has passed

Type ChangedMay 11

Solicitation → Sources Sought

Submission Closed

05/11/2021, 02:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency

Contacts2 people available

OfficeFALLS CHURCH, VA, 22042, USA

Organization / AgencyDepartment Of Defense → Defense Health Agency

Office AddressFALLS CHURCH, VA, 22042, USA

Contacts

Rhonda R Cato

contact@example.gov

+1 (555) 000-0000

MARVIN K. WALKER

contact@example.gov

Full Description

Defense Health Agency (DHA) Component Acquisition Executive (J-4) National Capital Region - Contracting Division (NCR-CD) Subj: Source Sought Announcement This is a sources sought/synopsis announcement issued by the Defense Health Agency (DHA) National Capital Region (NCR) as part of its market research, on behalf of the Fort Belvoir Community Hospital (FBCH), 9300 Dewitt Loop, Fort Belvoir, VA 22060, and Walter Reed National Military Medical Clinic (WRNMMC), 8901 Wisconsin Avenue Building 54 Bethesda, MD 20889, in accordance with FAR Part 13.303, Blanket Purchase Agreements (BPAs) and FAR 16.7, Agreements. The Government intends to award a Firm-Fixed Price, five year Blanket Purchase Agreement (BPA) for commercial items for the procurement of compounded products that are to provide treatment to both adult and neonatal patients being treated in the Neonatal Intensive Care Unit (NICU) These items include all adult and neonatal Total Parenteral Nutrition (TPN) admixtures of the following items; TrophAmine +NICU Starter Bag, FreAmine, PlenAmine, HepatAmine, NephrAmine, FreAmine HBC as well as amino acids admixtures; including, but not limited to, Clinisol, Travasol, and Aminosyn; 20% Fat Emulsion admixtures and Cariopelgia products; including Microplegia syringes and the attached items list, as needed. Currently, Central Admixture Pharmacy Services, (CAPS) Inc., 18012 Cowan, Suite 250, Irvine, CA, 92614-6810 is the products manufacturer and authorized distributor for the items described above (not all items inclusive). The estimated five year total of this BPA is $6,500,000.00. The NAICS code is 325412, Pharmaceutical Manufacturing Preparation Manufacturing, with a size standard of 1250. Federal Supply Class or Product Service Codes such as: 6505, 6506, 6515, 6520, J065, J070 are just a few classes of supplies, others not listed. This sources sought announcement is a request for information to be used for preliminary market research information and planning purposes only. This notice is not a request for competitive proposals. There will be no Request for Quote or Solicitation available for competitive proposals at the present time. Phone calls will not be accepted. This notice is not a request for competitive quotes; however, the government will consider responses to this notice within fifteen (15) days of this posting. Interested parties, may express their interest and provide a capabilities statement products list NLT Wednesday, 26 May 2021 at 10:00 AM EST. A determination by the government not to compete this requirement based upon responses to this notice is solely within the discretion of the government. Information received as a result of this notice will be considered solely for the purpose of determining whether to conduct a competitive procurement. Interested Parties: Please submit non-proprietary information - Only. The Government will not be responsible for proprietary or competition sensitive information contained in responses received. Responses to this announcement will not be returned. Responders are solely responsible for all expenses associated with responding to this announcement. Government will not be financially responsible for information received in response to this announcement. The points of contact for this action are: Rhonda R. Cato, Contracts Specialist; Email: rhonda.r.cato.civ@mail.mil and Marvin K. Walker; Contracting Officer, Email marvin.k.walker.civ@mail.mil